In Brief This Week: Abbott Molecular; Roche; Expression Analysis; Source MDx; Sigma-Aldrich, AMDeC; 5AM Solutions; More | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Abbott said this week that its Abbott Molecular business has received the CE Mark for its first DNA sequencing assay developed and introduced by the firm. The Abbott HBV Sequencing test has been developed to identify genomic sequences of the hepatitis B virus. Abbott said that the test is not intended for screening blood donors, plasma, or tissue donors for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.